游离的LIFα胞内功能片段对HL-60细胞的生长调节
[Abstract]:Leukemia inhibitory factor (LIF) is a multipotent cytokine, which acts on various cell tissues and plays different biological roles, and regulates cell growth, proliferation and differentiation widely. Such as inhibiting the differentiation of embryonic stem cells in vitro, stimulating platelet formation, hematopoietic cell proliferation, promoting osteoblast proliferation, promoting neurogen formation, proliferation of muscle satellite cells, and participating in neuromuscular repair. Participate in the acute stage of liver reaction, participate in the physiological and pathological process of inflammation, etc. These biological effects depend on its binding to the LIF receptor 伪 subunit (gp190) on the target cell membrane, forming heterodimer with another subunit (gp130) and activating the downstream signal transduction pathway. Gp190 (LIFR 伪 subunit) is a low affinity LIF specific receptor. It belongs to the hematopoietic receptor superfamily and lacks the activity of endogenous kinase. Soluble LIFR and transmembrane LIFR. exist in physiological state Soluble receptors, free from extracellular, transmembrane and intracellular regions, have antagonistic effects on the normal physiological effects of LIF. Transmembrane LIFR (gp190) contains three functional domains-BOX1,2,3.YXXQ sequence located at the distal end of the membrane (Y tyrosine, X arbitrary amino acid, Q glutamine), which binds specifically to the SH2 site of STAT3. Is there a intracellular free receptor in the cell? how does the intracellular receptor affect signal transduction and exert its biological effect? The effects of free peptides on cell proliferation and differentiation at the membrane receptor signal initiation site have been reported, suggesting that we, The single signal priming site of the single subunit can activate the corresponding signal transduction pathway in the cell under the condition of membrane separation. LIF signal transduction activates the JAK-STAT pathway and the RAS-MAPK pathway. We designed two kinds of small molecules, 190CT2 3 (including BOX2 3) and 190CT3 (including BOX3), according to the different functional domains of the intracellular region of gp190. We found that many functional domains of the intracellular region of gp190 become free peptides in the cell. It has different effects on cell differentiation and activates different signal molecules. In order to further verify the previous work and study the pathogenesis, two leukemia HL-60 cell lines, recombinant 190CT2 3 and 190CT3, were successfully obtained in this study, and the signal transduction pathway related to the YXXQ group site-directed mutation of 190CT3 was further studied. It was found that the proliferation of tumor cells expressing recombinant target genes (190CT2 3 and 190CT3) was inhibited, the cell maturation and differentiation were promoted, and the JAK/STAT3 pathway was activated. Through this study, we have determined the functional effect and phase of 190CT2 3190CT3 on the proliferation and differentiation of acute promyelocytic leukemia cell line HL-60 in the presence of different functional domains of gp190 in the presence of intracellular 190CT2 3190CT3.
【学位授予单位】:第二军医大学
【学位级别】:硕士
【学位授予年份】:2006
【分类号】:R341
【共引文献】
相关期刊论文 前8条
1 刘厚奇,汤淑萍,刘善荣,胡世杰,傅继梁;白血病抑制因子受体中gp130细胞内区诱导白血病细胞Meg-01内c-myc的表达[J];第二军医大学学报;2000年06期
2 刘厚奇,单继宽,汤淑萍,刘善荣;Fas调节白血病细胞HL-60内Stat3的表达和磷酸化[J];第二军医大学学报;2000年06期
3 赵吉清,董兆君,恽榴红,阮金秀;梭曼中毒诱导PC_(12)细胞JAKs表达[J];第三军医大学学报;2003年14期
4 单继宽,刘厚奇,汤淑萍,刘善荣;白血病抑制因子受体不同亚基细胞内区与HL-60细胞内STAT3激活的关系[J];免疫学杂志;2001年03期
5 杜冰,朱道银,唐恩洁;重组人白血病抑制因子体外诱导HL-60细胞凋亡与bc-l2及p53表达的关系[J];中国临床药理学与治疗学;2004年06期
6 刘厚奇!200433上海,单继宽!200433上海,汤淑萍!200433上海,刘善荣!200433上海;Fas死亡结构域调节白血病细胞Meg-01内c-myc的表达[J];中华血液学杂志;2001年01期
7 杨玲,刘善荣,汤淑萍,王凤玫,刘厚奇;白血病抑制因子受体α亚基胞内区远膜端对HL-60细胞增殖分化的影响[J];中华血液学杂志;2004年11期
8 张明生;周云峰;谢丛华;张文杰;周福祥;屈雪菊;;阻断细胞信号传导子和转录激活子6基因表达对人结肠癌细胞凋亡的影响[J];中华医学杂志;2006年02期
相关博士学位论文 前9条
1 黄定德;SHP-1和SHP-2在γ射线诱发的恶性肿瘤中作用的实验研究[D];第二军医大学;2002年
2 赵东红;肝癌细胞中Wnt及STAT3信号转导途径异常及其功能研究&中国家蚕抗菌肽基因的真核表达[D];南京师范大学;2002年
3 孙红颖;来源于人树突状细胞和骨髓基质细胞的两个新分子CRL2和CLM的克隆与功能的研究[D];浙江大学;2004年
4 杨帆;1. 慢性粒细胞性白血病融合基因bcr/abl第一外显子条件性基因打靶的实验研究 2. RNA干扰在哺乳动物细胞中的初步应用性研究[D];中国协和医科大学;2004年
5 张道宫;STAT3、Survivin在喉癌中的表达及AG490抑制喉癌细胞STAT3信号传导通路的研究[D];山东大学;2006年
6 于侠;重组白介素-12对小鼠病毒性心肌炎治疗机制的研究[D];吉林大学;2007年
7 祝华斌;溶瘤单纯疱疹病毒mtHSV的小鼠肉瘤治疗及其免疫机制研究[D];武汉大学;2007年
8 纪华;PIAS3在人胶质瘤中的表达及其对胶质瘤细胞凋亡和细胞周期的影响[D];第三军医大学;2007年
9 李光辉;RNA干扰STAT3基因对人胶质瘤干细胞增殖、分化、凋亡的影响[D];第三军医大学;2007年
相关硕士学位论文 前10条
1 潘俊江;STAT3、cyclinD1和Bcl-xl在原发性肝癌中的表达及其意义[D];重庆医科大学;2004年
2 单继宽;白血病抑制因子受体细胞内区结构与白血病细胞HL-60内分化、增殖信号的关系[D];第二军医大学;2001年
3 陈冰亚;卵巢上皮癌中VEGF、VEGFRs表达与STATs活化的相关性研究[D];浙江大学;2002年
4 胡波;酪氨酸蛋白磷酸酶Shp-2和白血病抑制因子影响HL-60细胞增殖与分化过程中的相互关系[D];第二军医大学;2002年
5 袁俊;1.STAT3在白介素6介导的肝癌细胞迁移和增殖中的作用研究 2.5-氟尿嘧啶与高能聚焦超声刀的结合在人回盲肠癌裸鼠肿瘤治疗中的作用[D];南京师范大学;2003年
6 季e鹲,
本文编号:2307920
本文链接:https://www.wllwen.com/yixuelunwen/binglixuelunwen/2307920.html